Erratum: Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts (PLoS ONE (2014) 9:1 (e85144) 10.1371/journal.pone.0085144);Role of caveolin-1 in atrial fibrillation as an anti-fibrotic signaling molecule in human atrial fibroblasts

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Yi, Shao Lei ^a,b   Liu, Xiao Jun ^a   Zhong, Jing Quan ^a   Zhang, Yun ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; COLLAGEN; GELATINASE A; GELATINASE B; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; FREEZE DRYING; GAIN OF FUNCTION MUTATION; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SINUS RHYTHM; WESTERN BLOTTING;

ADULT; AGED; ATRIAL FIBRILLATION; ATRIAL REMODELING; CAVEOLIN 1; COLLAGEN; DOWN-REGULATION; FEMALE; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84897999113     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0224190     Document Type: Erratum

References (47)

1. Yamada E (1955) The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1: 445-458.
2. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, et al. (1995) Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270: 15693-15701.
3. Fu C, He J, Li C, Shyy JY, Zhu Y (2010) Cholesterol increases adhesion of monocytes to endothelium by moving adhesion molecules out of caveolae. Biochim Biophys Acta 1801: 702-710.
4. Xu Y, Krause A, Hamai H, Harvey BG, Worgall TS, et al. (2010) Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA. PLoS One 5: e11004.
5. Harris J, Werling D, Hope JC, Taylor G, Howard CJ (2002) Caveolae and caveolin in immune cells: distribution and functions. Trends Immunol 23: 158-164. (Pubitemid 34178299)
6. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, et al. (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 272: 29337-29346. (Pubitemid 27498228)
7. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, et al. (1996) Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271: 2255-2261. (Pubitemid 26047818)
8. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, et al. (1999) Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19: 7289-7304. (Pubitemid 29493393)
9. Cruz JA, Bauer EM, Rodriguez AI, Gangopadhyay A, Zeineh NS, et al. (2012) Chronic hypoxia induces right heart failure in caveolin-1-/- mice. Am J Physiol Heart Circ Physiol 302: H2518-2527.
10. Pan CH, Lin JL, Lai LP, Chen CL, Stephen Huang SK, et al. (2007) Downregulation of angiotensin converting enzyme II is associated with pacing-induced sustained atrial fibrillation. FEBS Lett 581: 526-534. (Pubitemid 46149629)
11. Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, et al. (2013) Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 10: 90-100.
12. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, et al. (2002) Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54: 361-379. (Pubitemid 34327915)
13. Everett THt, Olgin JE (2007) Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 4: S24-27.
14. Verheule S, Sato T, Everett Tt, Engle SK, Otten D, et al. (2004) Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res 94: 1458-1465. (Pubitemid 38780318)
15. Miyasato SK, Loeffler J, Shohet R, Zhang J, Lindsey M, et al. (2011) Caveolin-1 modulates TGF-beta1 signaling in cardiac remodeling. Matrix Biol 30: 318-329.
16. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, et al. (2000) In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6: 1362-1367. (Pubitemid 32001020)
17. Oka N, Yamamoto M, Schwencke C, Kawabe J, Ebina T, et al. (1997) Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem 272: 33416-33421. (Pubitemid 28023695)
18. Tourkina E, Richard M, Gooz P, Bonner M, Pannu J, et al. (2008) Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 294: L843-861.
19. Bernatchez PN, Bauer PM, Yu J, Prendergast JS, He P, et al. (2005) Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. Proc Natl Acad Sci U S A 102: 761-766. (Pubitemid 40282739)
20. Turner NA, Porter KE, Smith WH, White HL, Ball SG, et al. (2003) Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism. Cardiovasc Res 57: 784-792. (Pubitemid 36254872)
21. Porter KE, Turner NA, O'Regan DJ, Ball SG (2004) Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovasc Res 64: 507-515. (Pubitemid 39505429)
22. Khan R, Sheppard R (2006) Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 118: 10-24.
23. Redondo S, Navarro-Dorado J, Ramajo M, Medina U, Tejerina T (2012) The complex regulation of TGF-beta in cardiovascular disease. Vasc Health Risk Manag 8: 533-539.
24. Levick SP, Brower GL (2008) Regulation of matrix metalloproteinases is at the heart of myocardial remodeling. Am J Physiol Heart Circ Physiol 295: H1375-1376.
25. Hori Y, Kashimoto T, Yonezawa T, Sano N, Saitoh R, et al. (2012) Matrix metalloproteinase-2 stimulates collagen-I expression through phosphorylation of focal adhesion kinase in rat cardiac fibroblasts. Am J Physiol Cell Physiol 303: C947-953.
26. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, et al. (1998) Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17: 6633-6648. (Pubitemid 28521797)
27. Chaudhary KR, Cho WJ, Yang F, Samokhvalov V, El-Sikhry HE, et al. (2013) Effect of ischemia reperfusion injury and epoxyeicosatrienoic acids on caveolin expression in mouse myocardium. J Cardiovasc Pharmacol 61: 258-263.
28. Piech A, Massart PE, Dessy C, Feron O, Havaux X, et al. (2002) Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 282: H219-231. (Pubitemid 34654153)
29. Uray IP, Connelly JH, Frazier OH, Taegtmeyer H, Davies PJ (2003) Mechanical unloading increases caveolin expression in the failing human heart. Cardiovasc Res 59: 57-66. (Pubitemid 36780949)
30. Jin Y, Lee SJ, Minshall RD, Choi AM (2011) Caveolin-1: a critical regulator of lung injury. Am J Physiol Lung Cell Mol Physiol 300: L151-160.
31. Patani N, Martin LA, Reis-Filho JS, Dowsett M (2012) The role of caveolin-1 in human breast cancer. Breast Cancer Res Treat 131: 1-15.
32. Engel D, Beckers L, Wijnands E, Seijkens T, Lievens D, et al. (2011) Caveolin-1 deficiency decreases atherosclerosis by hampering leukocyte influx into the arterial wall and generating a regulatory T-cell response. FASEB J 25: 3838-3848.
33. Murata T, Lin MI, Huang Y, Yu J, Bauer PM, et al. (2007) Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med 204: 2373-2382. (Pubitemid 47529323)
34. Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, et al. (2003) Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol 284: C457-474. (Pubitemid 36120083)
35. Zhao YY, Liu Y, Stan RV, Fan L, Gu Y, et al. (2002) Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci U S A 99: 11375-11380. (Pubitemid 34920933)
36. Jasmin JF, Rengo G, Lymperopoulos A, Gupta R, Eaton GJ, et al. (2011) Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 300: H1274-1281.
37. Volonte D, McTiernan CF, Drab M, Kasper M, Galbiati F (2008) Caveolin-1 and caveolin-3 form heterooligomeric complexes in atrial cardiac myocytes that are required for doxorubicin-induced apoptosis. Am J Physiol Heart Circ Physiol 294: H392-401.
38. Barth K, Pfleger C, Linge A, Sim JA, Surprenant A, et al. (2010) Increased P2X7R expression in atrial cardiomyocytes of caveolin-1 deficient mice. Histochem Cell Biol 134: 31-38.
39. Gramley F, Lorenzen J, Koellensperger E, Kettering K, Weiss C, et al. (2010) Atrial fibrosis and atrial fibrillation: the role of the TGF-beta1 signaling pathway. Int J Cardiol 143: 405-413.
40. Lin CS, Pan CH (2008) Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. Cell Mol Life Sci 65: 1489-1508.
41. Xiao H, Lei H, Qin S, Ma K, Wang X (2010) TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease. Clin Cardiol 33: 149-156.
42. Mariscalco G, Engstrom KG, Ferrarese S, Cozzi G, Bruno VD, et al. (2006) Relationship between atrial histopathology and atrial fibrillation after coronary bypass surgery. J Thorac Cardiovasc Surg 131: 1364-1372. (Pubitemid 43776070)
43. Lei B, Hitomi H, Mori T, Nagai Y, Deguchi K, et al. (2011) Effect of efonidipine on TGF-beta1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts. J Pharmacol Sci 117: 98-105.
44. Razani B, Zhang XL, Bitzer M, von Gersdorff G, Bottinger EP, et al. (2001) Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem 276: 6727-6738.
45. Moe GW, Laurent G, Doumanovskaia L, Konig A, Hu X, et al. (2008) Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure. J Card Fail 14: 768-776.
46. Seto SW, Krishna SM, Yu H, Liu D, Khosla S, et al. (2013) Impaired acetylcholine-induced endothelium-dependent aortic relaxation by caveolin-1 in angiotensin II-infused apolipoprotein-E (ApoE-/-) knockout mice. PLoS One 8: e58481.
47. Ma F, Li Y, Jia L, Han Y, Cheng J, et al. (2012) Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF beta/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS One 7: e35144.